Good Long-Term Outcomes after Metabolic Surgery in Diabetes

Restricted access

Ten-year follow-up data in patients with type 2 diabetes show better outcomes in those undergoing metabolic surgery, compared to conventional medical therapy, reports a study in The Lancet.

The researchers analyzed data from a previous open-label, single-center trial in which 60 obese patients with type 2 diabetes were randomly assigned to medical therapy, Roux-en-Y gastric bypass (RYGB), or biliopancreatic diversion (BPD). The main outcome of interest was diabetes remission, defined as glycated hemoglobin less than 6.5% with a fasting blood glucose level of less than 5.5 mmol and no diabetes medications for at least 1 year. Fifty-seven patients

Save